Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Tracon Pharmaceuticals, Inc. (TCON)  
$0.26 0.00 (0.00%) as of 4:30 Fri 4/5


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 13,680,000
Market Cap: 3.49(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.1322 - $0.67
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   TRACON Pharmaceuticals is a biopharmaceutical company. Co. has a collaboration and clinical trial agreement for the development of envafolimab, an investigational PD-L1 single-domain antibody for the treatment of soft tissue sarcoma in North America. Other clinical stage oncology product candidates include: YH001, which is a monospecific investigational CTLA-4 antibody, that Co. licensed from Eucure (Beijing) Biopharma Co., Ltd. and Biocytogen Pharmaceuticals (Beijing) Co., Ltd., TRC102, which is a small molecule for the treatment of mesothelioma, lung cancer, glioblastoma and solid tumors, and TJ004309, which is a CD73 antibody for the treatment of solid tumors.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 1,418,993
Total Buy Value $0 $0 $0 $1,892,637
Total People Bought 0 0 0 3
Total Buy Transactions 0 0 0 30
Total Shares Sold 0 0 4,764,008 4,765,667
Total Sell Value $0 $0 $1,401,571 $1,403,938
Total People Sold 0 0 1 2
Total Sell Transactions 0 0 1 3
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 241
  Page 3 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Theuer Charles President and CEO   •       •      –    2022-04-08 4 B $2.50 $5,000 D/D 2,000 226,518 2.81 -17%     
   Theuer Charles President and CEO   •       •      –    2022-03-30 4 B $2.70 $10,800 D/D 4,000 224,518 2.81 -29%     
   Brown Scott B. Chief Financial Officer   •       –      –    2022-03-29 4 B $2.82 $2,820 D/D 1,000 8,628 2.66 -31%     
   Theuer Charles President and CEO   •       •      –    2022-03-21 4 B $2.45 $2,940 D/D 1,200 220,518 2.73 -31%     
   Opaleye Management Inc. 10% Owner   –       –       •   2022-03-16 4 B $2.20 $4,917 I/I 2,235 2,837,735 1.42 -28%     
   Opaleye Management Inc. 10% Owner   –       –       •   2022-01-28 4 B $2.20 $1,100 I/I 500 2,820,500 1.42 -35%     
   Opaleye Management Inc. 10% Owner   –       –       •   2022-01-24 4 B $2.05 $35,603 I/I 17,363 317,363 1.5 -30%     
   Opaleye Management Inc. 10% Owner   –       –       •   2022-01-21 4 B $2.19 $76,811 I/I 35,000 315,000 1.5 -23%     
   Opaleye Management Inc. 10% Owner   –       –       •   2022-01-20 4 B $2.25 $47,952 I/I 21,312 310,000 1.5 -24%     
   Opaleye Management Inc. 10% Owner   –       –       •   2022-01-19 4 B $2.24 $53,080 I/I 23,688 308,688 1.5 -18%     
   Opaleye Management Inc. 10% Owner   –       –       •   2021-12-29 4 B $2.51 $131,362 I/I 52,325 305,000 1.5 -32%     
   Opaleye Management Inc. 10% Owner   –       –       •   2021-12-28 4 B $2.63 $52,950 I/I 20,125 285,000 1.5 -20%     
   Opaleye Management Inc. 10% Owner   –       –       •   2021-12-27 4 B $2.92 $255,103 I/I 87,325 265,000 1.5 -31%     
   Opaleye Management Inc. 10% Owner   –       –       •   2021-12-15 4 B $2.43 $53,287 I/I 21,964 252,675 1.5 -19%     
   Opaleye Management Inc. 10% Owner   –       –       •   2021-12-14 4 B $2.53 $106,344 I/I 42,000 250,711 1.5 -15%     
   Opaleye Management Inc. 10% Owner   –       –       •   2021-12-13 4 B $2.64 $40,154 I/I 15,204 243,711 1.5 -17%     
   Opaleye Management Inc. 10% Owner   –       –       •   2021-12-06 4 B $2.26 $51,474 I/I 22,733 242,507 1.5 3%     
   Opaleye Management Inc. 10% Owner   –       –       •   2021-12-03 4 B $2.30 $204,911 I/I 89,274 239,774 1.5 12%     
   Opaleye Management Inc. 10% Owner   –       –       •   2021-12-02 4 B $2.35 $24,660 I/I 10,500 230,500 1.5 12%     
   Opaleye Management Inc. 10% Owner   –       –       •   2021-12-01 4 B $2.40 $120,160 I/I 50,000 230,000 1.5 7%     
   Theuer Charles President and CEO   •       •      –    2021-11-05 4 B $3.41 $13,655 D/D 4,000 215,137 2.81 -26%     
   Theuer Charles President and CEO   •       •      –    2021-08-16 4 B $3.56 $10,680 D/D 3,000 207,732 2.81 -16%     
   Brown Scott B. Chief Financial Officer   •       –      –    2021-08-13 4 B $3.69 $3,695 D/D 1,000 7,628 2.66 2%     
   Pelletier Saundra L Director   –       •      –    2021-07-26 4 B $3.82 $25,002 D/D 6,545 12,045 2.39 -38%     
   Larue William R Director   –       •      –    2021-07-26 4 B $3.82 $25,002 D/D 6,545 7,883 2.39 -38%     

  241 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 3 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed